Mark B Abelson Columnista Experto de SIIC At Harvard: Associate Clinical Professor At Schepens: Senior Clinical Scientist Ophthalmology

LA OLOPATADINA ES EFICAZ Y SEGURA EN ENFERMEDADES ALERGICAS OCULARES Columnista Experto de SIIC Mark B Abelson Fecha de aprobación: 11 de Abril, 2006 Primera edición en siicsalud: 27 de Octubre, 2006 Sección Artículos originales, subsección Expertos del Mundo, página ../dat050/06o24000   Especialidad principal: Oftalmología. Especialidades relacionadas:  Alergia,  Farmacología,  Medicina Farmacéutica,  Medicina Interna. Berger W, Abelson MB, Gomes PJ et al. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Annals of Allergy, Asthma & Immunology. 95(4):361-71, 2005 Wagner RS, Abelson MB, Shapiro A, Torkildsen G. Evaluation of moxifloxacin, ciprofloxacin, Gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. Arch Ophthalmol. 123(9):1282-3, 2005 Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Turner FD, Wells DT, Robertson SM. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis. Curr Med Res Opin. 21(5):683-91, 2005 Ousler GW, Wilcox KA, Gupta G, Abelson MB. An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride. Annals of Allergy, Asthma & Immunology 93:460-464, 2004 Abelson MB, Ferzola NJ, McWhirter CL, Crampton HJ. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population. Pediatr Allergy Immunol. 15(6):551-7, 2004 Vogelson CT, Abelson MB, Pasquine T, Stephens DM, Gamache DA, Gross RD, Robertson SM, Yanni JM. Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration. Allergy Asthma Proc. 25(1):69-75, 2004 Dr.  Mark B Abelson Dirección profesional: 20 Staniford Street, MA 02114, Boston, EE.UU.

Bienvenidos a siicsalud
Acerca de SIIC] [Estructura de SIIC]

Sociedad Iberoamericana de Información Científica (SIIC)
Av. Belgrano 430, (C1092AAR), Buenos Aires, Argentina
atencionallector@siicsalud.com; Tel: +54 11 4342-4901; Fax: +54 11 4331-3305.
Casilla de Correo 2568, (C1000WAZ)  Correo Central, Buenos Aires.
Copyright siicsalud© 1997- 2007, Sociedad Iberoamericana de Información Científica (SIIC)